Global Digital Diabetes Management Market by Product & Services; by Device; by End User; by Region (North America, Europe, Asia-pacific, Latin America, Middle East Africa): Global Forecasts 2021 To 2027

The Global Digital Diabetes Management Market was valued at USD 6.9 Bn in 2020 and is expected to reach USD 30.7 Bn by 2027, with a growing CAGR of 23.9% during the forecast period.

Global Digital Diabetes Management Market Definition

Digital diabetes is defined as the process of managing diabetes using smart sensors and mobile apps for monitoring glucose level in the body. Digital healthcare platform helps to gather data to improve the outcomes of the diabetes. Digital diseases are managed by devices, applications, software and services. Adoption of digital technologies such as smart insulin pumps, CGM, bluetooth-enabled meters help to manage diabetes and enables patients to address and manage severity of disease by connecting with healthcare team and sharing real-time data.

Digital Diabetes Management Market

Global Digital Diabetes Management Market Dynamics

The driving factors influencing the global digital diabetes management market include increase in adoption of cloud-based solution for healthcare management and penetration of digital platforms in diabetes care. For instance, GlucoMe™ (Israle, ME) a digital diabetes platform helps to manage and measure glucose level automatically by the GlucoMe Smart Glucose Monitor. Through this app, data can be easily transferred to the physicians and patient’s smart phone that will be stored in the GlucoMe mobile app which would be analyzed by the cloud-based digital diabetes clinic. Such an emerging digital platform for the diabetes management is expected to boost the growth of digital diabetes management demand in the market during the forecast period. Furthermore, rising prevalence of chronic diseases such as diabetes and growing adoption of better solutions for diabetes care are expected to trigger the digital diabetes management demand during the forecast period. For instance, diabetes, being an epidemic disease, is estimated to affect more than ~400 Mn people worldwide. WHO (World Health Organization) projects that diabetes will be the 7th leading cause of death by the forecast period. Such rising diabetes cases are expected to trigger the digital diabetes management demand in the market during the forecast period.

On the contrary, lack of clinically validated data and issues related to data security is expected to hinder the growth of digital diabetes management demand in the market during the forecast period. For instance, 2020 proved to be an awful year for healthcare data breaches. More than 600 data violations of almost 500 records were reported to the Department of Health and Human Services office for civil rights. Approximately 2 Mn healthcare records were exposed during this period. Such growing data disruption is expected to hinder the growth of digital diabetes management demand during the forecast period.

Global Digital Diabetes Management Market Segmentation:

By Product & Services

  • Devices
    • Smart Insulin Pens
    • Smart Insulin Pumps
    • Continuous Glucose Monitoring System
    • Smart Glucose Meters
    • Others
  •  Applications
    • Obesity & Diet Management Apps
    • Diabetes & Blood Glucose Tracking Apps
  • Services

By Device

  • Wearable Devices
  • Handheld Devices

By End User

  • Self/Home Healthcare
  • Academic & Research Institutes
  • Hospitals & Specialty Diabetes Clinics

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Company Profiles and Competitive Intelligence

The key players operating in the digital diabetes management market are:

  • Medtronic
  • Abbott Laboratories
  • B. Braun
  • Dexcom
  • Roche Diagnostics
  • Tidepool
  • Insulet Corporation
  • Tandem Diabetes Care
  • Ascensia Diabetes Care
  • LifeScan
  • AgaMatrix
  • Glooko Inc.
  • DarioHealth
  • ACON Laboratories, Inc.,
  • Bayer AG
  • Becton, Dickinson and Company
  • Johnson and Johnson
  • Novo Nordisk A/S
  • Terumo corporation
  • Insulet Corporation
  • LifeScan

Based on product and services, devices segment is expected to hold the largest market share during the forecast period owing to increase in desirable insulin monitoring devices and software

Based on products and services, digital diabetes management market is broadly segmented into devices, applications, data management software, and services. Furthermore, devices segment is broadly sub-segmented into smart insulin pens, smart insulin pumps, continuous glucose monitoring system, and smart glucose meters. Device segment is expected to dominate the market during the forecast period due to growing demand for wireless diabetes care devices and rising acceptance of smart insulin delivering devices across the globe. Growing innovation for accurate dosing devices and increasing diabetic cases across the globe is expected to boost the digital diabetes management demand in the market during the forecast period. For instance, Roche (Switzerland) launched new Accu-Check instant system and innovative connect with blood glucose monitoring system which is expected to support the product portfolio of integrated personalised diabetes management approach. Accu-Check app hold Bluetooth connectivity to the mySugr app that would allow wireless transfer blood glucose results on the app. The data of mySugr is expected to be shared with healthcare professionals via Roche Diabetes Care Platform. Such products launch paves the way for the expansion of availability of digital diabetes care product in the digital diabetes management market during the forecast period.

Based on device, wearable devices segment is expected to dominate the market during the forecast period due to ease of accessibility and increasing behavioural interventions of people at their place

Based on device, digital diabetes management market is segmented into wearable and handheld devices. Wearable devices held largest market share in 2020 due to increased inclination of diabetic population towards wearables diabetes devices. Moreover, wearable devices segment is expected to hold largest market share owing to rise in scalability and the ability to test anywhere during the forecast period. Furthermore, integration of healthcare with internet of things and medical wearables helps to control & keep track on blood glucose level. For instance, widely used wearable diabetes devices such Dexcom G6 CGM System, a small wearable sensor that transmit glucose numbers to a smart device and V-GO, a product of Valeritas (Bridgewater, NJ) a disposable insulin pump that is worn on the skin provide supply of insulin at defined rate. Such invention of innovative wearable diabetes devices is expected to enhance the devices portfolio of Med-Tech companies in the digital diabetes management market across the globe during the forecast period.

Based on region, North America is expected to contribute highest to the market share during the forecast period due to continuous rising number of diabetic cases and high acceptance of technologically advanced monitoring devices

Based on region, North America held the largest market share in 2020 due to established quality of diabetes management system and presence of large pool of diabetic patients. Moreover, increase in healthcare infrastructure, strong government support in terms of funding & grants for research & development, and favourable reimbursement policies are expected to leverage the digital diabetes management demand during the forecast period. In addition, increase in penetration of technology and software in medical devices and rise in public acceptance for smart diabetes monitoring devices are expected to propel the growth of digital diabetes management during the forecast period. For instance, according to the American Diabetes Association, 2018, ~35 Mn Americans had diabetes and nearly ~1.6 Mn Americans has type-1 diabetes including 190,000 children and adolescents. About 27% of diabetic affected population belongs to the age group of 65 years. Rising prevalence of diabetes into American population leads to increase in adoption of digital diabetes devices that fuels the growth of digital diabetes management market during the forecast period.

The report also provides in-depth analysis of digital diabetes management market dynamics such as drivers, restraints, opportunities, and challenges

Drivers

  • Growing government investments in R&D associated with digital technology for diabetes
  • Rising demand for self-diabetes monitoring
  • Increasing adoption of technology of chronic disease management
  • Growing awareness regarding continuous glucose monitoring devices

Restraints

  • Inadequate reimbursement policies
  • Lack of training provisions

Opportunity

  • Rising number of digital diabetes management start-ups for healthcare management
  • Accumulation of big data related to the diabetes
  • Penetration artificial intelligence in digital diabetes management

Challenges

  • Inadequate evidence on app/software accuracy
  • Poor interoperability and standardization

COVID-19 Impact on the Digital Diabetes Management Market Analysis

Covid-19 has created havoc for the global health system. Diabetic patients have significantly affected by the pandemic situation due to decrease in conventional type of consultation by face-to-face which may result in higher risk of covid-19 exposure. Diabetic population developed inclination towards self-diabetes monitoring devices and software. This led to increase in adoption of digital diabetes management demand for the software and smart insulin apps across the globe. Decrease in number of patients visits in the hospitals led to increase in adoption of mobile apps for digital diabetes management market for the health monitoring. Sudden covid-19 outbreak has increased the importance of self-monitoring and self- dosing medical devices. However, due to lockdown, manufacturing of medical devices and supply chain had diversly affected the growth of digital diabetes management demand across the globe.

 The report also provides an in-depth analysis of key trends in Digital Diabetes Management market

Sr. No. Trends Impact
1 Growing development for more design-focused diabetes app for patient care is expected to drift the attention of manufacturing companies Positive
2 Implication of clinically driven solutions for digital diabetes care to develop patient’s conviction towards digital apps and software Positive
3 Exploitation of patients personal data Negative

The report also provides an in-depth analysis of recent news developments and investments

  • In February 2021, Eli Lilly & Co. (US) signed a collaboration agreement with Welldoc’s (Columbia, Maryland) digital health platform with their therapies and various connected insulin devices. This collaboration is expected to be the new version of Welldoc’s long-running diabetes management app named BlueStar. This app is expected to hold dosing data for insulins produced by the Lilly and anticipate launching connected insulin pen in near future. This collaboration is expected to provide digital diabetes care platform for Lilly to enhance their insulin product portfolio in digital terms.
  • In October 2021, LifeScan,Inc (US) launched their OneTouch solution for wellness programs for diabetes management. OneTouch solution is expected to be available for US consumer and healthcare professionals in early 2022. OneTouch solution is a diabetes monitoring tool with digital solutions that include digital app named OneTouch Reveal that is expected to keep a track on diabetes and blood sugar devices monitoring. This launch is expected to enhance diabetic patient care experience and would help the company to be the leader in the new health solution market.

The unique insights provided by this report also includes the following:

  • In-depth Value Chain Analysis
  • Opportunity Mapping
  • Sector Snapshot
  • Key Players Positioning Matrix
  • Regulatory Scenario
  • Strategies Adopted-Benchmarking Heat Map
  • Market Trends
  • Covid-19 Impact Analysis
  • Product Comparison
  • Pre & Post COVID 19 Impacts on Digital Diabetes Management Market
  • Competitive Landscape

Frequently Asked Questions (FAQs)

The global digital diabetes management market was valued at USD 6.9 Bn in 2020 and is anticipated to reach USD 30.7 Bn by 2027.

The global digital diabetes management market is estimated to grow at a compound annual growth rate (CAGR) of 23.9% during forecast period.

In the base year 2020, North America accounted for highest share in the market.

Lack of trained professionals and lack of clinically validated diabetes management procedures restraint the growth of global digital diabetes management market.

As per expert opinions, increase in adoption of connected devices and apps for better diabetes solution management, rising concern to improve quality of life, increase in disposable income, and growing geriatric population will drive the growth of digital diabetes management market.

Few key players include, but not limit up to: Becton, Dickinson and Company, Johnson and Johnson, Novo Nordisk A/S, Terumo corporation, Insulet Corporation, LifeScan, and Abbott Laboratories.

Related Reports

Need specific market information ?

Ask for free product review call with the author

Share your specific research requirements for a customized report

Request for due diligence and consumer centric studies

Request for study updates, segment specific and country level reports

  1.  Introduction
    1. Product Outline
    2. What is Digital Diabetes Management?
    3. Analysis of Digital Diabetes Management Market
    4. Covid -19 Impact
    5. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Threats
    6. Technology Overview
  2. Regulatory Landscape for Digital Diabetes Management Market
    1. Regulations and Standards
  3. Digital Diabetes Management Market by Product & Service
    1. Devices
      1. Smart Insulin Pens
      2. Smart Insulin Pumps
      3. Continuous Glucose Monitoring System
      4. Smart Glucose Meters
      5. Others
    2.  Applications
      1. Obesity & Diet Management Apps
      2. Diabetes & Blood Glucose Tracking Apps
    3. Data Management Software & Platforms
    4. Services
  4. Digital Diabetes Management Market by Device Type
    1. Wearable Devices
    2. Handheld Devices
  5. Digital Diabetes Management Market by End User
    1. Self/Home Healthcare
    2. Academic & Research Institutes
    3. Hospitals & Specialty Diabetes Clinics
  6. Regional Analysis
    1. North America
      1. US
      2. Canada
    2. Europe
      1. Germany
      2. UK
      3. France 
      4. Spain
      5. Italy  
      6. Rest Of Europe
    3. Asia Pacific
      1. China
      2. India
      3. Japan
      4. Australia
      5. Rest Of Asia Pacific
    4. Latin America
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    5. Middle East Africa (MEA)
      1. GCC
      2. Rest of MEA
  7.  Key Market Trends / Recent Developments
    1. Emerging Technologies
    2. Opportunity Mapping
    3. Critical Success Factors
    4. Customer Preferences
  8. Competitive Scenario
    1. Mergers and Acquisitions
    2. Investments
    3. Joint Ventures
    4. New Product Launches
    5. Ranking of Key Players
    6. Presence of Players by Geographies
  9. Key global players
    1. Medtronic
    2. Abbott Laboratories
    3. B. Braun
    4. Dexcom
    5. Roche Diagnostics
    6. Tidepool
    7. Novo Nordisk A/S
    8. Insulet Corporation
    9. Tandem Diabetes Care
    10. Ascensia Diabetes Care
    11. LifeScan
    12. AgaMatrix
    13. Glooko Inc.
    14. DarioHealth
    15. ACON Laboratories, Inc.,
    16. Bayer AG
    17. Others

Choose License

License Type
Ask for Customization

Why Choose AllTheResearch?

  • Monthly market updates for 6 months
  • Online access of reports
  • Options to buy sections of report
  • Critically analysed research on Quadrant Positioning of your company.
  • Syndicated report along with a supplementary report with objective-based study
  • Get profiled in the reports.Expanding your visibility across our network of readers and viewers
  • We provide local market data in local language on request
  • A complementary co-branded white paper
  • Flat consulting fee based exclusive studies. Consult at the price of syndicate
  • Access to expert team for free transaction advisory service.
Speak to Analyst

Quick Inquiry

Follow Us

Choose License

License Type
Ask for Customization